MedPath

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Registration Number
NCT00003736
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Brief Summary

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for breast cancer. Diagnostic procedures such as MRI may improve the ability to detect breast cancer.

PURPOSE: Screening and diagnostic trial to study the effectiveness of MRI scans in women who are at high risk for developing breast cancer.

Detailed Description

OBJECTIVES:

* Estimate the diagnostic yield and positive predictive value of breast magnetic resonance imaging (MRI) for the detection of cancer in women who are at greater than 25% lifetime risk for developing breast cancer.

* Compare the diagnostic yield and positive predictive value of MRI with conventional breast cancer screening (mammography and physical examination) for the detection of breast cancer in women with a greater than 25% lifetime risk of developing breast cancer.

OUTLINE: All patients receive a physical exam within 90 days of initial MRI scan. Patients undergo a two view screening mammogram within 3 months prior to study entry. Patients undergo an MRI with gadolinium contrast at entry. All lesions identified as suspicious on physical examination, mammography, or MRI undergo a core needle or excisional biopsy.

PROJECTED ACCRUAL: A total of 200 patients will be accrued for this study within 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

University of Washington Medical Center

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

Roswell Park Cancer Institute

πŸ‡ΊπŸ‡Έ

Buffalo, New York, United States

Lineberger Comprehensive Cancer Center, UNC

πŸ‡ΊπŸ‡Έ

Chapel Hill, North Carolina, United States

Hartford Hospital

πŸ‡ΊπŸ‡Έ

Hartford, Connecticut, United States

Porter Adventist Hospital

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

University of Toronto

πŸ‡¨πŸ‡¦

Toronto, Ontario, Canada

University of Colorado Cancer Center

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

Lombardi Cancer Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Simmons Cancer Center - Dallas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

UCSF Cancer Center and Cancer Research Institute

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

University of Pennsylvania Cancer Center

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Cancer Center at the University of Virginia

πŸ‡ΊπŸ‡Έ

Charlottesville, Virginia, United States

Β© Copyright 2025. All Rights Reserved by MedPath